Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Microbial Corrosion01:24

Microbial Corrosion

Microbiologically Influenced Corrosion (MIC) is a significant form of material degradation caused by the metabolic activities of microorganisms. This phenomenon poses substantial challenges across various industries, including oil and gas, maritime, and water treatment sectors.MIC occurs when microorganisms, such as bacteria, archaea, and fungi, colonize metal surfaces, forming biofilms that alter the local electrochemical environment. These biofilms can lead to the production of corrosive...
Surface Membrane Barriers01:18

Surface Membrane Barriers

The skin and mucous membranes serve as the primary line of defense against pathogens by providing both physical and chemical protection. These barriers are essential in preventing the entry and establishment of microbes, thereby maintaining the integrity of the host.
The outer layer of the skin, the epidermis, is a robust barrier comprising layers of closely packed keratinized cells. This dense arrangement prevents microbes from penetrating the body. The periodic shedding of epidermal cells...
Antimicrobial Effectiveness01:28

Antimicrobial Effectiveness

The effectiveness of antimicrobial agents depends on various factors influencing their ability to eliminate microbial populations. Larger microbial populations require more time for complete eradication, emphasizing the importance of population size analysis when evaluating antimicrobial efficacy.Microbial resistance to antimicrobial agents varies significantly. Highly resilient microorganisms include endospores, gram-negative bacteria, and non-enveloped viruses, while prions are exceptionally...
Chemical Agents for Microbial Control01:27

Chemical Agents for Microbial Control

Chemicals play important roles in controlling microbial growth by targeting microbial structures and functions as sanitizers, antiseptics, disinfectants, and sterilants.Alcohols are commonly used sanitizers, effectively disrupting lipid membranes, which compromises cell integrity. They are also used as antiseptics and disinfectants due to their rapid action and versatility.Phenols and their derivatives phenolics , known for denaturing proteins and disrupting cell membranes, are particularly...
Biological Methods for Microbial Control01:28

Biological Methods for Microbial Control

Biological agents offer an effective means of controlling microbial growth by leveraging natural processes like predation, competition, and the secretion of antimicrobial substances.Predatory bacteria such as Bdellovibrio species target and kill pathogens like Salmonella and E. coli. They are widely used in poultry farms to control infections. Myxococcus species help combat plant-pathogenic fungi. These naturally occurring predators serve as eco-friendly alternatives to chemical pesticides and...
Microorganisms in Medicine and Therapeutics01:29

Microorganisms in Medicine and Therapeutics

Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Implementing the collaborative chronic care model for mental health: a nonrandomized clinical trial.

Implementation science communications·2026
Same author

Duration of clinically meaningful improvement in pain as a patient-centered endpoint in acute pain trials.

Pain·2026
Same author

Provider and leadership attitudes toward telemental health at sites with high levels of video, phone, and in-person care: A qualitative analysis.

Psychological services·2026
Same author

Complication outcomes in retroauricular interpolated flaps after Mohs surgery: A single-center retrospective study.

Journal of the American Academy of Dermatology·2026
Same author

Impact of Wetting-Drying Cycles on Iron Oxide Transformations and Contaminant Mobilization in a Replica Legacy Radioactive Waste Trench.

Environmental science & technology·2026
Same author

Response to Xu et al., "Letter to Editor 'Mohs micrographic surgery reduces the risk of reconstruction with positive margins, repeat surgeries, and time to definitive reconstruction compared to conventional excision of hand and foot melanomas: A retrospective cohort study'".

Journal of the American Academy of Dermatology·2026
Same journal

Erratum for the Research Article "Detecting supramolecular organic nanoparticles during heat wave".

Science (New York, N.Y.)·2026
Same journal

Local signals, systemic decline.

Science (New York, N.Y.)·2026
Same journal

The mechanics of liver regeneration.

Science (New York, N.Y.)·2026
Same journal

Computing in a memory with physics.

Science (New York, N.Y.)·2026
Same journal

Retraction.

Science (New York, N.Y.)·2026
Same journal

Making time.

Science (New York, N.Y.)·2026
See all related articles

Related Experiment Video

Updated: Jul 3, 2026

Establishing the Minimal Bactericidal Concentration of an Antimicrobial Agent for Planktonic Cells (MBC-P) and Biofilm Cells (MBC-B)
06:36

Establishing the Minimal Bactericidal Concentration of an Antimicrobial Agent for Planktonic Cells (MBC-P) and Biofilm Cells (MBC-B)

Published on: January 2, 2014

Whither or wither microbicides?

Robert M Grant1, Dean Hamer, Thomas Hope

  • 1J. David Gladstone Institutes, University of California-San Francisco, San Francisco, CA 94518, USA.

Science (New York, N.Y.)
|July 26, 2008
PubMed
Summary
This summary is machine-generated.

Microbicide research for HIV-1 prevention faces challenges due to trial failures and poor strategy. Future success requires better decision-making and validated animal models for developing new HIV prevention methods.

Related Experiment Videos

Last Updated: Jul 3, 2026

Establishing the Minimal Bactericidal Concentration of an Antimicrobial Agent for Planktonic Cells (MBC-P) and Biofilm Cells (MBC-B)
06:36

Establishing the Minimal Bactericidal Concentration of an Antimicrobial Agent for Planktonic Cells (MBC-P) and Biofilm Cells (MBC-B)

Published on: January 2, 2014

Area of Science:

  • * Infectious Diseases
  • * Public Health
  • * Drug Development

Background:

  • * Microbicide research for HIV-1 sexual transmission prevention has encountered significant setbacks.
  • * Past efficacy trials have yielded disappointing results, eroding confidence in microbicides.
  • * Challenges include poor coordination and the use of unvalidated targets in Phase III studies.

Purpose of the Study:

  • * To analyze the challenges facing microbicide research after recent trial failures.
  • * To identify critical factors hindering the development of effective HIV-1 prevention strategies.
  • * To propose necessary improvements for advancing future microbicide candidates.

Main Methods:

  • * Review of past microbicide efficacy trials and research coordination.
  • * Analysis of decision-making processes for advancing candidates into clinical trials.
  • * Emphasis on the role of animal models in preclinical development.

Main Results:

  • * Disappointing outcomes from multiple efficacy trials have created substantial challenges.
  • * Poor coordination and the selection of nonvalidated scientific targets have hampered progress.
  • * Mistrust has emerged regarding the efficacy of microbicides for HIV-1 prevention.

Conclusions:

  • * The field requires a critical reappraisal of how new microbicide candidates are selected for clinical trials.
  • * The strategic use of appropriate animal models is crucial for the advancement of next-generation microbicides.
  • * Improved coordination and validated scientific targets are essential for restoring confidence and achieving success in HIV-1 prevention research.